Hui Xian Real Estate Investment Trust (87001.HK)
CNY 0.51
(0.0%)
CNY 0.51
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1 Billion | 894 Million | 1.09 Billion | 1 Billion | 1.45 Billion | 1.53 Billion |
| Net Income | -353 Million | -1.31 Billion | -185 Million | -833 Million | 933 Million | 1.09 Billion |
| Depreciation & Amortization | 313 Million | 370 Million | 385 Million | 395 Million | 361 Million | 358 Million |
| Deferred income taxes | -82 Million | -85 Million | -93 Million | -99 Million | -101 Million | -102 Million |
| Stock-based compensation | 82 Million | 85 Million | 93 Million | 99 Million | 101 Million | 102 Million |
| Change in working capital | -20 Million | -72 Million | -79 Million | -79 Million | -24 Million | 19 Million |
| Other non-cash items | 1.06 Billion | 1.91 Billion | 978 Million | 1.52 Billion | 188 Million | 66 Million |
| Investing Cash Flow | 2.44 Billion | 373 Million | -88 Million | -375 Million | 1.21 Billion | 1.39 Billion |
| Investments in PPE | -146 Million | -182 Million | -88 Million | -89 Million | -160 Million | -149 Million |
| Acquisitions | - | 1 Million | - | - | -1 Billion | -1.03 Billion |
| Investment purchases | -4.89 Billion | -6.1 Billion | -7.88 Billion | -11.65 Billion | -2.43 Billion | -3.62 Billion |
| Sales/Maturities of investments | 7.48 Billion | 6.52 Billion | 7.73 Billion | 11.22 Billion | 3.62 Billion | 4.91 Billion |
| Other Investing Activities | 3 Million | 132 Million | 141 Million | 146 Million | 1.18 Billion | 1.28 Billion |
| Financing Cash Flow | -2.15 Billion | -1.96 Billion | -997 Million | -2.14 Billion | -785 Million | -2.93 Billion |
| Debt repayment | -1.38 Billion | -1.95 Billion | -4.25 Billion | -1.37 Billion | -673 Million | -1.55 Billion |
| Dividends payments | -378 Million | -470 Million | -705 Million | -512 Million | -1.14 Billion | -1.1 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8 Million | 463 Million | 3.96 Billion | -259 Million | 1.03 Billion | -269 Million |
| Accounts receivables | 8 Million | -16 Million | 18 Million | -7 Million | -6 Million | -7 Million |
| Accounts payables | -7 Million | 16 Million | -71 Million | -1 Million | 13 Million | 5 Million |
| Inventory | 3 Million | 3 Million | 2 Million | 1 Million | 2 Million | -1 Million |
| Other working capital | -24 Million | -75 Million | -28 Million | -72 Million | -33 Million | 22 Million |
| Cash at beginning of period | 2.17 Billion | 2.86 Billion | 2.85 Billion | 4.36 Billion | 2.48 Billion | 2.48 Billion |
| Cash at end of period | 3.47 Billion | 2.17 Billion | 2.86 Billion | 2.85 Billion | 4.36 Billion | 2.48 Billion |
| Capital Expenditure | -146 Million | -182 Million | -88 Million | -89 Million | -160 Million | -149 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.3 Billion | -699 Million | 14 Million | -1.51 Billion | 1.88 Billion | -7 Million |
| Free Cash Flow | 859 Million | 712 Million | 1.01 Billion | 918 Million | 1.29 Billion | 1.38 Billion |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -366 Million | -353 Million | -124 Million | -438 Million | -1.31 Billion | -244 Million |
| Depreciation & Amortization | 157 Million | 313 Million | 158 Million | 155 Million | 370 Million | 193 Million |
| Deferred income taxes | - | -82 Million | -344 Million | - | -85 Million | -416 Million |
| Stock-based compensation | 28 Million | 82 Million | 41 Million | 41 Million | 85 Million | 43 Million |
| Change in working capital | - | -20 Million | -13 Million | - | -72 Million | -72 Million |
| Other non-cash items | 691 Million | 1.06 Billion | 516 Million | 1.08 Billion | 1.91 Billion | 856 Million |
| Investing Cash Flow | -314 Million | 2.44 Billion | 1 Billion | 1.34 Billion | 373 Million | -1.26 Billion |
| Investments in PPE | -54 Million | -146 Million | -5 Million | -141 Million | -182 Million | -85 Million |
| Acquisitions | - | - | - | - | 1 Million | 1 Million |
| Investment purchases | -1.64 Billion | -4.89 Billion | -1.59 Billion | -3.39 Billion | -6.1 Billion | -3.35 Billion |
| Sales/Maturities of investments | 1.34 Billion | 7.48 Billion | 2.66 Billion | 4.82 Billion | 6.52 Billion | 2.23 Billion |
| Other Investing Activities | -314 Million | 3 Million | -60 Million | 60 Million | 132 Million | -65 Million |
| Financing Cash Flow | -1.19 Billion | -2.15 Billion | -1.42 Billion | -346 Million | -1.96 Billion | -268 Million |
| Debt repayment | -1 Billion | -1.38 Billion | -1.38 Billion | - | -1.95 Billion | -3 Million |
| Dividends payments | -8 Million | -378 Million | -200 Million | -178 Million | -470 Million | -319 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -184 Million | -8 Million | 160 Million | -168 Million | 463 Million | 54 Million |
| Accounts receivables | - | 8 Million | 8 Million | - | -16 Million | -16 Million |
| Accounts payables | - | -7 Million | - | - | 16 Million | - |
| Inventory | - | 3 Million | 3 Million | - | 3 Million | 3 Million |
| Other working capital | - | -24 Million | -24 Million | - | -75 Million | -59 Million |
| Cash at beginning of period | 3.47 Billion | 2.17 Billion | 3.65 Billion | 2.17 Billion | 2.86 Billion | 3.28 Billion |
| Cash at end of period | 2.47 Billion | 3.47 Billion | 3.47 Billion | 3.65 Billion | 2.17 Billion | 2.17 Billion |
| Capital Expenditure | -54 Million | -146 Million | -5 Million | -141 Million | -182 Million | -85 Million |
| Effect of forex changes on cash | - | - | -3.47 Billion | 2.17 Billion | - | -2.17 Billion |
| Net cash flow / Change in cash | -999 Million | 1.3 Billion | -189 Million | 1.48 Billion | -699 Million | -1.11 Billion |
| Free Cash Flow | 456 Million | 859 Million | 229 Million | 350 Million | 712 Million | 334 Million |
9699
REPCOHOME
BDMS-R
EU
CNT
4061